Cargando…
Deubiquitinases in cancer
Deubiquitinases are deubiquitinating enzymes (DUBs), which remove ubiquitin from proteins, thus regulating their proteasomal degradation, localization and activity. Here, we discuss DUBs as anti-cancer drug targets.
Autores principales: | Wei, Rongbin, Liu, Xiaodong, Yu, Weixin, Yang, Tianshu, Cai, Wenping, Liu, Junjun, Huang, Xiao, Xu, Guo-tong, Zhao, Shouliang, Yang, Jianhua, Liu, Shangfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536986/ https://www.ncbi.nlm.nih.gov/pubmed/25972356 |
Ejemplares similares
-
Drug-induced premature senescence model in human dental follicle stem cells
por: Zhai, Yuanfen, et al.
Publicado: (2016) -
Expression profiling of white sponge nevus by RNA sequencing revealed pathological pathways
por: Cai, Wenping, et al.
Publicado: (2015) -
Erratum to: Expression profiling of white sponge nevus by RNA sequencing revealed pathological pathways
por: Cai, Wenping, et al.
Publicado: (2015) -
RNA-Sequencing Analyses Demonstrate the Involvement of Canonical Transient Receptor Potential Channels in Rat Tooth Germ Development
por: Yang, Jun, et al.
Publicado: (2017) -
A novel mutation of adenomatous polyposis coli (APC) gene results in the formation of supernumerary teeth
por: Yu, Fang, et al.
Publicado: (2017)